Effectiveness of Virtual Reality Psychotherapy and Yoga on Student Performance Anxiety (VRvsHY)

March 15, 2025 updated by: Marcel-Alexandru Gaina, Grigore T. Popa University of Medicine and Pharmacy

A Comparative Study on the Effectiveness of Virtual Reality-Facilitated Psychotherapy Vs. Yoga-Based Interventions for Managing Performance Anxiety Among Students

The goal of this pilot clinical trial is to compare two non-pharmacological interventions-Virtual Reality (VR) and Yoga techniques-in reducing performance anxiety in students aged 16-35. Performance anxiety, commonly experienced during public speaking and examinations, affects academic performance and well-being. The main questions it aims to answer are:

Does the VR-based guided meditation intervention reduce performance anxiety more effectively than Yoga-based relaxation techniques? Do participants experience better emotional regulation and improved quality of life with either intervention? Researchers will compare the VR intervention group to the Yoga intervention group to determine which intervention better alleviates anxiety symptoms and fosters improved emotional regulation during school performance.

Participants will:

Attend six to ten sessions of either VR-based guided meditation or Yoga-based relaxation over a period of four weeks.

Complete questionnaires to assess their anxiety levels, emotional regulation, and quality of life before and after the intervention.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Detailed Description This randomized controlled trial (RCT) is designed to evaluate the comparative effectiveness of two non-pharmacological interventions-Virtual Reality (VR) and Yoga techniques-in reducing performance anxiety among students aged 16-35. Performance anxiety, a specific type of anxiety experienced in academic and public speaking situations, has a significant impact on students' academic performance and overall mental well-being. The study aims to explore accessible, non-invasive interventions that can be easily integrated into educational settings to help manage this condition.

The trial will compare VR-based guided relaxation and exposure therapy, delivered via the Guided Meditation VR software, with Yoga-based relaxation techniques, incorporating Hatha Yoga postures (asanas), breathing exercises (pranayama), and meditation (dhyana). Both interventions focus on providing mental relaxation, emotional regulation, and coping strategies to manage performance-related anxiety without the use of medications.

Rationale:

The choice of interventions is based on evidence supporting both VR and Yoga as effective tools for anxiety reduction. Virtual Reality has been shown to provide immersive environments that enhance relaxation, while allowing exposure to stressful situations in a controlled manner, which is crucial for performance anxiety. Guided Meditation VR enables students to practice mindfulness in virtual settings designed to reduce stress, using calming visuals and guided meditative exercises.

In contrast, Yoga is an ancient practice that has been widely studied for its ability to reduce anxiety through physical movement, controlled breathing, and meditation. By incorporating mindfulness and physical postures, Yoga may promote relaxation and help students improve their ability to regulate their physiological and emotional responses to anxiety-inducing situations.

Study Design:

The study will randomly assign participants to either a VR intervention group or a Yoga intervention group. Both interventions will be delivered over a period of 4 weeks, with 6-10 sessions, each lasting approximately 30-40 minutes. The interventions will be offered in a structured format, with the VR sessions focusing on mindfulness and relaxation in immersive environments, and the Yoga sessions integrating movement, breath control, and meditation.

Each participant's anxiety levels will be measured at baseline, immediately after the intervention, and during a follow-up period to assess the sustained effects of the interventions on anxiety reduction.

Virtual Reality Intervention:

The VR intervention will utilize the Guided Meditation VR software, accessible via VR headsets such as Oculus Quest 2 or HTC Vive Flow. The sessions will involve participants entering virtual environments specifically designed to promote relaxation and mindfulness, such as serene beaches, forests, and mountains. These environments are paired with guided meditation sessions aimed at calming the mind and reducing anxiety. Additionally, participants will be encouraged through guided imagery to engage in public speaking or exam scenarios, while using mindfulness techniques to reduce their anxiety responses. The immersive nature of VR allows participants to practice coping strategies in a safe, controlled setting.

Yoga Intervention:

The Yoga intervention will follow the principles of Hatha Yoga, focusing on practices that have been shown to promote relaxation and reduce anxiety. Sessions will incorporate a combination of physical postures (asanas), breath control exercises (pranayama), and meditation (dhyana). Participants will be guided through a series of gentle yoga postures aimed at reducing physical tension and promoting mental clarity. The breathing techniques and meditation components will focus on calming the mind and regulating the body's stress response, making this intervention particularly relevant for managing performance anxiety.

Feasibility and Acceptability:

In addition to the primary objective of reducing performance anxiety, this study will assess the feasibility and acceptability of integrating these interventions into student life. The ease of implementing VR and Yoga techniques in academic environments will be evaluated, as well as participant feedback on the usability and perceived effectiveness of each intervention.

Significance:

This trial addresses the growing need for accessible mental health interventions that can be seamlessly integrated into educational settings. By exploring the comparative benefits of Virtual Reality and Yoga, the study aims to provide insights into non-pharmacological treatments that may reduce the burden of anxiety on students. The results could inform future interventions that help students manage their mental health and academic performance more effectively.

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Iasi, Romania, 700506
        • Romanian Academy of Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age between 18 and 35 years;
  • Currently enrolled university students or recent graduates (within the last 2 years) pursuing further studies (e.g., Master's or PhD) in the same area of expertise;
  • Mild to moderate levels of trait anxiety as measured by validated psychological inventories (e.g., STAI-Y1); Able to fully understand study procedures;
  • No prior exposure to the specific interventions being tested (i.e., Virtual Reality Psychotherapy or Yoga interventions);
  • Able to provide informed consent to participate in the study.

Exclusion Criteria:

  • History of severe psychiatric disorders (e.g., schizophrenia, bipolar disorder);
  • Currently receiving psychiatric or psychological treatment, including ongoing psychotropic medication;
  • History of adverse reactions to Virtual Reality technology (e.g., motion sickness, dizziness, allergy to headset and controllers materials);
  • Significant physical limitations preventing participation in yoga exercises;
  • Pregnant individuals, due to physical limitations related to yoga and potential psychological sensitivity to Virtual Reality;
  • Individuals not fluent in Romanian and English, as the interventions and assessments will be conducted in Romanian, with the Virtual Reality intervention partly in English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Reality facilitated Psychotherapy for Performance Anxiety
Participants in this arm will undergo Virtual Reality (VR) facilitated Psychotherapy aimed to alleviate performance anxiety. The sessions will combine cognitive-behavioural therapy (CBT), exposure therapy and relaxation within VR environments. The program will be provided by a qualified integrative psychotherapist, 2-3 times per week, each lasting 30-60 minutes, over 4 weeks. The programme will be individualized for each participant, based on their anxiety levels and progression, including in-depth experiences to promote performance resilience.

Participants in this VR-facilited psychotherapy group will receive their treatment via Oculus Quest 2 and HTC Vive Flow wireless, standalone headsets systems to provide a comfortable immersive environment. The more hardware-intensive experiences will be carried out on Oculus Rift S headsets powered by high-end laptops.

Sessions will last 30-60 minutes each, ranging from six to ten sessions within two to four weeks. The treatment will include reducing anxiety and improving emotion regulation through Cognitive-Behavioural techniques such as mindfulness, acceptance and commitement therapy, exposure therapy and 4-7-8 breathing. The same investigator will conduct all sessions to ensure uniformity. Additionally, subjects will undergo unsupervised VR at home with pre-programmed headsets to minimize investigator bias and maintain cosistancy of the relaxation and cognitive-behavioral strategies.

Other Names:
  • VRG
Experimental: Yoga Training for Performance Anxiety
Participants in this arm will undergo a Yoga-based intervention for performance anxiety. This therapy includes facilitated yoga sequences consisting of breathing (Pranayama), exercises (Asanas) and meditation, for body-mental relaxation. The course will be led by expert yoga instructors for 2x60 to 90 min sessions, twice per week, within 2 to 4 weeks. The trainers will focus on promoting mindfulness, reducing anxiety, and improving focus to help participants manage daily performance stressors.

The Yoga group members will be guided in a yoga class focused on managing performance anxiety. The interventions will consist of body exercises (Asanas), breath (Pranayama) and meditation to increase relaxation, consciousness and resilience; typical yoga postures like Surya Namaskar, Padahastasana, Virabhadrasana, Bhujangasana and Shavasana will be included in the session, as will breathing movements like Ujjayi (Victory Breath).

Each class will be 60-90 minutes long, and 6-10 classes will be taught in two to four weeks. The technique will be progressive, from the basic to more advanced postures as participants cultivate confidence and resilience. All classes will conclude with meditation to ease tension and cultivate mindfulness.

Other Names:
  • YG

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trait Anxiety Reduction
Time Frame: Measured 1 day before the first intervention session and within 1 day after the final intervention session of the program and also after major events such as faculty exams.
The trait anxiety reduction will be measured with the Romanian validated version of the State-Trait Anxiety Inventory (STAI-Y2) Participant assessment: Previously trained and licensed STAI researchers will assess participants reported scores. The STAI-Y2 score ranges from 20 to 80, with higher scores indicating higher anxiety levels.
Measured 1 day before the first intervention session and within 1 day after the final intervention session of the program and also after major events such as faculty exams.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State Anxiety Reduction
Time Frame: Measured at baseline, before each session, and 30 minutes after the interventions.
We will assess state anxiety using the Romanian validated version of the State-Trait Anxiety Inventory (STAI-Y1); scores range from 20 to 80, with higher scores indicating higher levels of anxiety.
Measured at baseline, before each session, and 30 minutes after the interventions.
Emotional Regulation Strategies
Time Frame: Measured 1 day before the first intervention session and within 1 day after the final intervention session of the program.
Emotional regulation strategies will be measured by the Emotion Regulation Questionnaire (ERQ), which measures two basic processes in emotional regulation: cognitive reappraisal and expressive suppression.
Measured 1 day before the first intervention session and within 1 day after the final intervention session of the program.
Quality of Life Improvement
Time Frame: Measured 1 day before the first intervention session and within 1 day after the final intervention session of the program.
The quality of life will be measured through the Romanian population validated Quality of Life Inventory (QoLI) to reflect the participants' wellbeing and the impact of academic stress and anxiety. The scores will be assessed by a previously QoLi trained and licenced investigator.
Measured 1 day before the first intervention session and within 1 day after the final intervention session of the program.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance Anxiety
Time Frame: Measured 1 day before the first intervention session and within 1 day after the final intervention session of the program.
Measured using the Academic Anxiety Inventory for anxiety regarding particular academic assignments.
Measured 1 day before the first intervention session and within 1 day after the final intervention session of the program.
Qualitative Intervention Feedback
Time Frame: 60 minutes before and after each intervention.
Through self-administered ratings of participants' comfort/discomfort with interventions at the end of each session, evaluations of effectiveness and overall perceptions of the Virtual Reality or Yoga intervention.
60 minutes before and after each intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Marcel A Găină, Ass. Prof., University of Medicine and Pharmacy "Grigore T. Popa" Iași
  • Study Director: Liviu A Măgurianu, Sci.Res.III, Romanian Academy of Sciences "Gh. Zane" Institute Iasi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2024

Primary Completion (Estimated)

March 8, 2025

Study Completion (Estimated)

July 31, 2025

Study Registration Dates

First Submitted

October 9, 2024

First Submitted That Met QC Criteria

October 11, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 15, 2025

Last Verified

October 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GAR56-IRB-466/24
  • ICES 145/02.04.2024 (Registry Identifier: Scientific Council "Gheorghe Zane" Romanian Academy)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The IPD to be shared will consist of all anonymized information from the primary and secondary outcome measures, baseline information, and any other supporting data such as participant demographics. The data dictionaries, as well as any datasets supporting the published results will be distributed. These data will be available for future analysis, verification of the study results, or replication by other researchers.

Time Frame:

Access Criteria:

IPD Sharing Time Frame

The IPD and supporting information will be published starting 6 months after the study results are published and will be available 2 years from the publication.

IPD Sharing Access Criteria

Researchers who want to access the aforementioned data will need to make a formal request with a full scientific proposal outlining how the data will be used. The request will be reviewed by the external Data Safety and Monitoring Board (DSMB) review to verify that these requests are scientifically valid and ethical, in order to ensure participant data safety. The researchers who receive approval will have to sign a data-sharing contract regarding data protection within the specific utilization established terms.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Performance Anxiety

Clinical Trials on Virtual Reality Psychotherapy

Subscribe